{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T04:34:45Z","timestamp":1793853285155,"version":"4.6.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1124\/dmd.122.001038","type":"journal-article","created":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T21:05:55Z","timestamp":1667509555000},"page":"155-164","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Renal Transporter Alterations in Patients with Chronic Liver Diseases: Nonalcoholic Steatohepatitis, Alcohol-Associated, Viral Hepatitis, and Alcohol-Viral Combination"],"prefix":"10.1016","volume":"51","author":[{"given":"Kayla L.","family":"Frost","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4215-9434","authenticated-orcid":false,"given":"Joseph L.","family":"Jilek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shripad","family":"Sinari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert R.","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean","family":"Billheimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen H.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan J.","family":"Cherrington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.122.001038_bib1","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1080\/00313029500169053","article-title":"Renal glomerular lesions in unselected patients with cirrhosis undergoing orthotopic liver transplantation","volume":"27","author":"Axelsen","year":"1995","journal-title":"Pathology"},{"key":"10.1124\/dmd.122.001038_bib2","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1053\/j.ackd.2015.05.003","article-title":"GFR Estimating Equations and Liver Disease","volume":"22","author":"Beben","year":"2015","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1124\/dmd.122.001038_bib3","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1124\/dmd.114.058529","article-title":"Proton pump inhibitors inhibit methotrexate transport by renal basolateral organic anion transporter hOAT3","volume":"42","author":"Chioukh","year":"2014","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.122.001038_bib4","doi-asserted-by":"crossref","first-page":"5737","DOI":"10.3390\/ijms21165737","article-title":"Extrahepatic Drug Transporters in Liver Failure: Focus on Kidney and Gastrointestinal Tract","volume":"21","author":"Dro\u017adzik","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1124\/dmd.122.001038_bib5","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1124\/pr.111.004614","article-title":"Organic anion transporters and their implications in pharmacotherapy","volume":"64","author":"Emami Riedmaier","year":"2012","journal-title":"Pharmacol Rev"},{"key":"10.1124\/dmd.122.001038_bib6","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1002\/cpt.1115","article-title":"Disease-Associated Changes in Drug Transporters May Impact the Pharmacokinetics and\/or Toxicity of Drugs: A White Paper From the International Transporter Consortium","volume":"104","author":"Evers","year":"2018","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.122.001038_bib7","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1093\/toxsci\/kfac070","article-title":"Increased Renal Expression of Complement Components in Patients With Liver Diseases: Nonalcoholic Steatohepatitis, Alcohol-Associated, Viral Hepatitis, and Alcohol-Viral Combination","volume":"189","author":"Frost","year":"2022","journal-title":"Toxicol Sci"},{"key":"10.1124\/dmd.122.001038_bib8","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/toxsci\/kfu156","article-title":"Increased susceptibility to methotrexate-induced toxicity in nonalcoholic steatohepatitis","volume":"142","author":"Hardwick","year":"2014","journal-title":"Toxicol Sci"},{"key":"10.1124\/dmd.122.001038_bib9","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1124\/dmd.116.070722","article-title":"Lansoprazole Exacerbates Pemetrexed-Mediated Hematologic Toxicity by Competitive Inhibition of Renal Basolateral Human Organic Anion Transporter 3","volume":"44","author":"Ikemura","year":"2016","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.122.001038_bib10","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/biostatistics\/4.2.249","article-title":"Exploration, normalization, and summaries of high density oligonucleotide array probe level data","volume":"4","author":"Irizarry","year":"2003","journal-title":"Biostatistics"},{"key":"10.1124\/dmd.122.001038_bib11","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1016\/j.apsb.2021.05.030","article-title":"Altered cisplatin pharmacokinetics during nonalcoholic steatohepatitis contributes to reduced nephrotoxicity","volume":"11","author":"Jilek","year":"2021","journal-title":"Acta Pharm Sin B"},{"key":"10.1124\/dmd.122.001038_bib12","doi-asserted-by":"crossref","first-page":"940","DOI":"10.5858\/arpa.2021-0339-RA","article-title":"Pathologic Diagnosis of Nonalcoholic Fatty Liver Disease","volume":"146","author":"Lai","year":"2022","journal-title":"Arch Pathol Lab Med"},{"key":"10.1124\/dmd.122.001038_bib13","doi-asserted-by":"crossref","first-page":"408","DOI":"10.2165\/00003495-198937040-00003","article-title":"Zidovudine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy","volume":"37","author":"Langtry","year":"1989","journal-title":"Drugs"},{"key":"10.1124\/dmd.122.001038_bib14","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3390\/jpm8020014","article-title":"Genetic Heterogeneity of SLC22 Family of Transporters in Drug Disposition","volume":"8","author":"Lozano","year":"2018","journal-title":"J Pers Med"},{"key":"10.1124\/dmd.122.001038_bib15","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1124\/dmd.116.074294","article-title":"Quantitative Prediction of Human Renal Clearance and Drug-Drug Interactions of Organic Anion Transporter Substrates Using In Vitro Transport Data: A Relative Activity Factor Approach","volume":"45","author":"Mathialagan","year":"2017","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.122.001038_bib16","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/ki.2011.322","article-title":"Drug dosing consideration in patients with acute and chronic kidney disease-a clinical update from Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"80","author":"Matzke","year":"2011","journal-title":"Kidney Int"},{"key":"10.1124\/dmd.122.001038_bib17","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1016\/j.cgh.2019.07.060","article-title":"Contemporary Epidemiology of Chronic Liver Disease and Cirrhosis","volume":"18","author":"Moon","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1124\/dmd.122.001038_bib18","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1124\/dmd.112.049676","article-title":"Alcohol cirrhosis alters nuclear receptor and drug transporter expression in human liver","volume":"41","author":"More","year":"2013","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.122.001038_bib19","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.2215\/CJN.02440314","article-title":"Handling of Drugs, Metabolites, and Uremic Toxins by Kidney Proximal Tubule Drug Transporters","volume":"10","author":"Nigam","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1124\/dmd.122.001038_bib20","first-page":"273","article-title":"Update and trends on pharmacokinetic studies in patients with impaired renal function: practical insight into application of the FDA and EMA guidelines","volume":"10","author":"Paglialunga","year":"2017","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1124\/dmd.122.001038_bib21","doi-asserted-by":"crossref","first-page":"e490","DOI":"10.1097\/TXD.0000000000000935","article-title":"Outcomes of Liver Transplantation in Patients on Renal Replacement Therapy: Considerations for Simultaneous Liver Kidney Transplantation Versus Safety Net","volume":"5","author":"Pita","year":"2019","journal-title":"Transplant Direct"},{"key":"10.1124\/dmd.122.001038_bib22","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/s41581-018-0080-9","article-title":"Estimated GFR: time for a critical appraisal","volume":"15","author":"Porrini","year":"2019","journal-title":"Nat Rev Nephrol"},{"key":"10.1124\/dmd.122.001038_bib23","first-page":"407","article-title":"Hepatic glomerulosclerosis--light microscopic study of autopsy cases","volume":"18","author":"Sakaguchi","year":"1968","journal-title":"Acta Pathol Jpn"},{"key":"10.1124\/dmd.122.001038_bib24","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1124\/jpet.300.3.918","article-title":"Human organic anion transporters and human organic cation transporters mediate renal antiviral transport","volume":"300","author":"Takeda","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.122.001038_bib25","doi-asserted-by":"crossref","first-page":"E48","DOI":"10.1111\/j.1399-0012.2011.01542.x","article-title":"Renal histological lesions and outcome in liver transplant recipients","volume":"26","author":"Tsapenko","year":"2012","journal-title":"Clin Transplant"},{"key":"10.1124\/dmd.122.001038_bib26","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1002\/cpt.1699","article-title":"Quantitative Proteomics and Mechanistic Modeling of Transporter-Mediated Disposition in Nonalcoholic Fatty Liver Disease","volume":"107","author":"Vildhede","year":"2020","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.122.001038_bib27","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1124\/dmd.116.071050","article-title":"Transporter Expression in Liver Tissue from Subjects with Alcoholic or Hepatitis C Cirrhosis Quantified by Targeted Quantitative Proteomics","volume":"44","author":"Wang","year":"2016","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.122.001038_bib28","doi-asserted-by":"crossref","DOI":"10.12659\/AOT.925891","article-title":"Clinical Relevance of Kidney Biopsy in Patients Qualified for Liver Transplantation and After This Procedure in the Model for End-stage Liver Disease (MELD) Era: Where Are We Today?","volume":"25","author":"Wieliczko","year":"2020","journal-title":"Ann Transplant"},{"key":"10.1124\/dmd.122.001038_bib29","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/TP.0000000000002484","article-title":"Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: Implications for Liver Transplantation","volume":"103","author":"Younossi","year":"2019","journal-title":"Transplantation"},{"key":"10.1124\/dmd.122.001038_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107647","article-title":"Regulation of organic anion transporters: Role in physiology, pathophysiology, and drug elimination","volume":"217","author":"Zhang","year":"2021","journal-title":"Pharmacol Ther"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624009310?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624009310?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.122.001038","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T08:58:47Z","timestamp":1739955527000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624009310"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S0090955624009310"],"URL":"https:\/\/doi.org\/10.1124\/dmd.122.001038","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Renal Transporter Alterations in Patients with Chronic Liver Diseases: Nonalcoholic Steatohepatitis, Alcohol-Associated, Viral Hepatitis, and Alcohol-Viral Combination","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.122.001038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}